July 4, 2012
With the holidays right around the corner, we want to take this
opportunity to wish you all a warm and pleasant summer.
So far, 2012 has proved to be yet another exciting year in the
world of Uniferon - not least thanks to our entries on a variety of
new markets and our continued consolidation on the world's most
important pig farming markets.
We are genuinely proud of the fact that almost 600 million pigs
are injected with quality iron from Pharmacosmos each year. And we
dedicate this to the high and homogenous quality of the product,
the transparency of the entire production process and most
importantly the positive effect on the piglets.
More than ever, an optimum iron selection can make the
difference in a competitive world, and pig farmers all over the
world have realized the significant relation between iron and the
performance of a highly prolific sow herd. We believe that the near
future will bring about an even stronger focus on improved health,
growth and best practice, and we are here to help pig farmers'
businesses grow through this process.
At Pharmacosmos, we look forward to resume work after summer, and
we hope you will enjoy your summer holiday - whether on the beach
on in the pigsty.
About Uniferon
Uniferon is a modern improved iron hydrogenated dextran based on
a natural formula, which is approved for global use:
Uniferon is manufactured without the use of any organic solvents
or cyanide, thus, avoiding trace residues of these impurities.
Pharmacosmos manufactures iron dextran of high quality and unique
purity for customers worldwide. Uniferon is the only injectable
iron brand for piglets approved in the EU, the US and Asia.
About Pharmacosmos
Headquartered in Denmark, Pharmacosmos is a family-owned,
international healthcare company with more than 50 years of
innovation and leadership in iron- and carbohydrate-based
treatments and solutions for human and animal use.
A research-based company, its ongoing R&D programme focuses
on improving the lives of patients with iron deficiency with or
without anaemia. More than 1 billion people live with iron
deficiency anaemia and it is the leading cause of death for an
estimated 180,000 people every year. This makes it one of the
largest global health challenges of our time.
Pharmacosmos has subsidiaries in the Nordics, the UK and the US
and its products are marketed in more than 80 countries across the
world. Its manufacturing facilities are approved, among others, by
the Danish Medicines Agency and the US FDA.